The Group has reported a robust performance with adjusted EBITDA flat at £5.8m, an outturn that was in line with management’s expectations given Covid disruptions and the phased exit of (profitable) third-party MRI component manufacture. Whilst the order book is robust, notwithstanding some contract delays, the timing of contract revenue recognition is noted as providing good visibility over H2 revenues, leaving the Group on-track to deliver full year expectations. Our forecasts remain unchanged ....
23 Feb 2022
Results in line with management expectations
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Results in line with management expectations
Avingtrans plc (AVG:LON) | 390 0 0.0% | Mkt Cap: 129.1m
- Published:
23 Feb 2022 -
Author:
Richard Hickinbotham -
Pages:
6
The Group has reported a robust performance with adjusted EBITDA flat at £5.8m, an outturn that was in line with management’s expectations given Covid disruptions and the phased exit of (profitable) third-party MRI component manufacture. Whilst the order book is robust, notwithstanding some contract delays, the timing of contract revenue recognition is noted as providing good visibility over H2 revenues, leaving the Group on-track to deliver full year expectations. Our forecasts remain unchanged ....